Brief: Verrica Pharma Reports Cash And Cash Equivalents
21/02/2023 11:29
Feb 21 (Reuters) - Verrica Pharmaceuticals Inc VRCA.O :
* VERRICA PHARMACEUTICALS INC - AS OF DECEMBER 31, 2022, IT
HAD
APPROXIMATELY $34.3 MILLION OF CASH AND CASH EQUIVALENTS
Source text: (https://bit.ly/3IIp4Ig)
Further company coverage: VRCA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Verrica Pharmaceuticals
See all newsVerrica Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Verrica Pharma reports wider-than-expected Q2 adj loss per share
Verrica Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Verrica Pharmaceuticals Q1 revenue rises on YCANTH demand
Brief: Verrica Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Data